Trial of Enhanced Pre-Consent Discussion

Pediatric Crohn's Disease Clinical Trial

Official title:
Trial of Enhanced Pre-Consent Discussion

Status Completed

Clinical Trial Summary

Nested within the COMBINE pragmatic clinical trial, the investigators will conduct a cluster randomized controlled trial to determine whether, in parents (of children with Crohn's Disease) or patients > 18 years old being approached for trial participation, a pre-consent discussion enhanced with decision aids is more effective than the standard pre-consent discussion in transferring knowledge to parents/patients related to trial participation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02869880
Study type	Interventional
Source	Children's Hospital Medical Center, Cincinnati
Contact
Status	Completed
Phase	N/A
Start date	October 2016
Completion date	July 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02578238` - Post-Marketing Surveillance of Humira in Korean Pediatric Crohn's Disease (CD) Patients Under the "New-Drug Re-examination"
Completed	`NCT02772965` - Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy	Phase 3
Completed	`NCT01580670` - Clinical Study of TA-650 in Pediatric Patients With Crohn's Disease	Phase 3
Withdrawn	`NCT01752790` - Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease	Phase 4
Terminated	`NCT02694042` - Mission is Remission®: How Can a Disease Self-management Website Change Care?	N/A